Risk factor
Strong trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas...
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV
Target Price
The average target price of VTRS is 17 and suggests 18% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell